Biological Safety Cabinet Market Research Report by Type (Class I, Class II, Class III), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Laboratories), Application (Industrial, R&D, Academic) - Global Industry Revenue Estimation and Demand Forecast to 2030

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segment

1.4.1. Market size breakdown, by type

1.4.2. Market size breakdown, by end user

1.4.3. Market size breakdown, by application

1.4.4. Market size breakdown, by region

1.4.5. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

6.1. Market Dynamics

6.1.1. Trends

6.1.2. Drivers

6.1.3. Restraints/challenges

6.1.4. Impact analysis of drivers/restraints

6.2. Impact of COVID-19

6.3. Porter’s Five Forces Analysis

6.3.1. Bargaining power of buyers

6.3.2. Bargaining power of suppliers

6.3.3. Threat of new entrants

6.3.4. Intensity of rivalry

6.3.5. Threat of substitutes

Chapter 7. Global Market

7.1. Overview

7.2. Market Revenue, by Type (2017–2030)

7.3. Market Revenue, by End User (2017–2030)

7.4. Market Revenue, by Application (2017–2030)

7.5. Market Revenue, by Region (2017–2030)

Chapter 8. North America Market

8.1. Overview

8.2. Market Revenue, by Type (2017–2030)

8.3. Market Revenue, by End User (2017–2030)

8.4. Market Revenue, by Application (2017–2030)

8.5. Market Revenue, by Country (2017–2030)

Chapter 9. Europe Market

9.1. Overview

9.2. Market Revenue, by Type (2017–2030)

9.3. Market Revenue, by End User (2017–2030)

9.4. Market Revenue, by Application (2017–2030)

9.5. Market Revenue, by Country (2017–2030)

Chapter 10. APAC Market

10.1. Overview

10.2. Market Revenue, by Type (2017–2030)

10.3. Market Revenue, by End User (2017–2030)

10.4. Market Revenue, by Application (2017–2030)

10.5. Market Revenue, by Country (2017–2030)

Chapter 11. LATAM Market

11.1. Overview

11.2. Market Revenue, by Type (2017–2030)

11.3. Market Revenue, by End User (2017–2030)

11.4. Market Revenue, by Application (2017–2030)

11.5. Market Revenue, by Country (2017–2030)

Chapter 12. MEA Market

12.1. Overview

12.2. Market Revenue, by Type (2017–2030)

12.3. Market Revenue, by End User (2017–2030)

12.4. Market Revenue, by Application (2017–2030)

12.5. Market Revenue, by Country (2017–2030)

Chapter 13. U.S. Market

13.1. Overview

13.2. Market Revenue, by Type (2017–2030)

13.3. Market Revenue, by End User (2017–2030)

13.4. Market Revenue, by Application (2017–2030)

Chapter 14. Canada Market

14.1. Overview

14.2. Market Revenue, by Type (2017–2030)

14.3. Market Revenue, by End User (2017–2030)

14.4. Market Revenue, by Application (2017–2030)

Chapter 15. Germany Market

15.1. Overview

15.2. Market Revenue, by Type (2017–2030)

15.3. Market Revenue, by End User (2017–2030)

15.4. Market Revenue, by Application (2017–2030)

Chapter 16. France Market

16.1. Overview

16.2. Market Revenue, by Type (2017–2030)

16.3. Market Revenue, by End User (2017–2030)

16.4. Market Revenue, by Application (2017–2030)

Chapter 17. U.K. Market

17.1. Overview

17.2. Market Revenue, by Type (2017–2030)

17.3. Market Revenue, by End User (2017–2030)

17.4. Market Revenue, by Application (2017–2030)

Chapter 18. Italy Market

18.1. Overview

18.2. Market Revenue, by Type (2017–2030)

18.3. Market Revenue, by End User (2017–2030)

18.4. Market Revenue, by Application (2017–2030)

Chapter 19. Spain Market

19.1. Overview

19.2. Market Revenue, by Type (2017–2030)

19.3. Market Revenue, by End User (2017–2030)

19.4. Market Revenue, by Application (2017–2030)

Chapter 20. Japan Market

20.1. Overview

20.2. Market Revenue, by Type (2017–2030)

20.3. Market Revenue, by End User (2017–2030)

20.4. Market Revenue, by Application (2017–2030)

Chapter 21. China Market

21.1. Overview

21.2. Market Revenue, by Type (2017–2030)

21.3. Market Revenue, by End User (2017–2030)

21.4. Market Revenue, by Application (2017–2030)

Chapter 22. India Market

22.1. Overview

22.2. Market Revenue, by Type (2017–2030)

22.3. Market Revenue, by End User (2017–2030)

22.4. Market Revenue, by Application (2017–2030)

Chapter 23. Australia Market

23.1. Overview

23.2. Market Revenue, by Type (2017–2030)

23.3. Market Revenue, by End User (2017–2030)

23.4. Market Revenue, by Application (2017–2030)

Chapter 24. South Korea Market

24.1. Overview

24.2. Market Revenue, by Type (2017–2030)

24.3. Market Revenue, by End User (2017–2030)

24.4. Market Revenue, by Application (2017–2030)

Chapter 25. Brazil Market

25.1. Overview

25.2. Market Revenue, by Type (2017–2030)

25.3. Market Revenue, by End User (2017–2030)

25.4. Market Revenue, by Application (2017–2030)

Chapter 26. Mexico Market

26.1. Overview

26.2. Market Revenue, by Type (2017–2030)

26.3. Market Revenue, by End User (2017–2030)

26.4. Market Revenue, by Application (2017–2030)

Chapter 27. Saudi Arabia Market

27.1. Overview

27.2. Market Revenue, by Type (2017–2030)

27.3. Market Revenue, by End User (2017–2030)

27.4. Market Revenue, by Application (2017–2030)

Chapter 28. South Africa Market

28.1. Overview

28.2. Market Revenue, by Type (2017–2030)

28.3. Market Revenue, by End User (2017–2030)

28.4. Market Revenue, by Application (2017–2030)

Chapter 29. U.A.E. Market

29.1. Overview

29.2. Market Revenue, by Type (2017–2030)

29.3. Market Revenue, by End User (2017–2030)

29.4. Market Revenue, by Application (2017–2030)

Chapter 30. Competitive Landscape

30.1. List of Market Players and Their Offerings

30.2. Competitive Benchmarking of Key Players

30.3. Product Benchmarking of Key Players

30.4. Recent Strategic Developments

Chapter 31. Company Profiles

31.1. Thermo Fisher Scientific Inc.

31.1.1. Business overview

31.1.2. Product and service offerings

31.1.3. Key financial summary

31.2. Kewaunee Scientific Corporation

31.2.1. Business overview

31.2.2. Product and service offerings

31.2.3. Key financial summary

31.3. ACMAS Technologies Pvt. Ltd.

31.3.1. Business overview

31.3.2. Product and service offerings

31.4. Germfree Laboratories Inc.

31.4.1. Business overview

31.4.2. Product and service offerings

31.5. NuAire Inc.

31.5.1. Business overview

31.5.2. Product and service offerings

31.6. Air Science LLC

31.6.1. Business overview

31.6.2. Product and service offerings

31.7. Berner International

31.7.1. Business overview

31.7.2. Product and service offerings

31.8. BIOBASE Group

31.8.1. Business overview

31.8.2. Product and service offerings

31.9. Erlab Inc.

31.9.1. Business overview

31.9.2. Product and service offerings

31.10. Esco Lifesciences

31.10.1. Business overview

31.10.2. Product and service offerings

31.11. The Baker Company

31.11.1. Business overview

31.11.2. Product and service offerings

31.12. Labconco Corporation

31.12.1. Business overview

31.12.2. Product and service offerings

31.13. Cruma

31.13.1. Business overview

31.13.2. Product and service offerings

31.14. LaboGene

31.14.1. Business overview

31.14.2. Product and service offerings

31.15. Biolab Scientific Ltd.

31.15.1. Business overview

31.15.2. Product and service offerings

Chapter 32. Appendix

32.1. Abbreviations

32.2. Sources and References

32.3. Related Reports

 

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 5 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 6 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 7 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 8 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 9 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 10 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 11 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 12 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 13 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY REGION, $M (2017–2022)

TABLE 14 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY REGION, $M (2023–2026)

TABLE 15 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY REGION, $M (2027–2030)

TABLE 16 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 17 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 18 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 19 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 20 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 21 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 22 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 23 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 24 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 25 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2017–2022)

TABLE 26 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2023–2026)

TABLE 27 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2027–2030)

TABLE 28 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 29 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 30 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 31 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 32 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 33 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 34 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 35 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 36 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 37 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2017–2022)

TABLE 38 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2023–2026)

TABLE 39 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2027–2030)

TABLE 40 APAC BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 41 APAC BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 42 APAC BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 43 APAC BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 44 APAC BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 45 APAC BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 46 APAC BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 47 APAC BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 48 APAC BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 49 APAC BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2017–2022)

TABLE 50 APAC BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2023–2026)

TABLE 51 APAC BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2027–2030)

TABLE 52 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 53 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 54 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 55 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 56 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 57 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 58 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 59 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 60 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 61 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2017–2022)

TABLE 62 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2023–2026)

TABLE 63 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2027–2030)

TABLE 64 MEA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 65 MEA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 66 MEA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 67 MEA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 68 MEA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 69 MEA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 70 MEA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 71 MEA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 72 MEA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 73 MEA BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2017–2022)

TABLE 74 MEA BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2023–2026)

TABLE 75 MEA BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2027–2030)

TABLE 76 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 77 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 78 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 79 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 80 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 81 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 82 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 83 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 84 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 85 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 86 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 87 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 88 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 89 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 90 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 91 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 92 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 93 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 94 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 95 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 96 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 97 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 98 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 99 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 100 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 101 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 102 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 103 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 104 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 105 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 106 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 107 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 108 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 109 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 110 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 111 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 112 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 113 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 114 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 115 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 116 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 117 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 118 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 119 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 120 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 121 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 122 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 123 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 124 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 125 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 126 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 127 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 128 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 129 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 130 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 131 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 132 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 133 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 134 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 135 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 136 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 137 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 138 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 139 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 140 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 141 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 142 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 143 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 144 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 145 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 146 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 147 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 148 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 149 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 150 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 151 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 152 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 153 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 154 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 155 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 156 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 157 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 158 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 159 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 160 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 161 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 162 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 163 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 164 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 165 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 166 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 167 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 168 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 169 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 170 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 171 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 172 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 173 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 174 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 175 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 176 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 177 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 178 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 179 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 180 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 181 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 182 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 183 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 184 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 185 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 186 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 187 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 188 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 189 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 190 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 191 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 192 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 193 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 194 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 195 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 196 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 197 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 198 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 199 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 200 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 201 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 202 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 203 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 204 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 205 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 206 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 207 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 208 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 209 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 210 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 211 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 212 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 213 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 214 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 215 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 216 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 217 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 218 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 219 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 220 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2022)

TABLE 221 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2023–2026)

TABLE 222 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2027–2030)

TABLE 223 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2022)

TABLE 224 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2023–2026)

TABLE 225 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2027–2030)

TABLE 226 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2022)

TABLE 227 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2023–2026)

TABLE 228 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2027–2030)

TABLE 229 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE

TABLE 230 THERMO FISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY

TABLE 231 KEWAUNEE SCIENTIFIC CORPORATION – AT A GLANCE

TABLE 232 KEWAUNEE SCIENTIFIC CORPORATION – KEY FINANCIAL SUMMARY

TABLE 233 ACMAS TECHNOLOGIES PVT. LTD. – AT A GLANCE

TABLE 234 GERMFREE LABORATORIES INC. – AT A GLANCE

TABLE 235 NUAIRE INC. – AT A GLANCE

TABLE 236 AIR SCIENCE LLC – AT A GLANCE

TABLE 237 BERNER INTERNATIONAL – AT A GLANCE

TABLE 238 BIOBASE GROUP – AT A GLANCE

TABLE 239 ERLAB INC. – AT A GLANCE

TABLE 240 ESCO LIFESCIENCES – AT A GLANCE

TABLE 241 THE BAKER COMPANY – AT A GLANCE

TABLE 242 LABCONCO CORPORATION – AT A GLANCE

TABLE 243 CRUMA – AT A GLANCE

TABLE 244 LABOGENE – AT A GLANCE

TABLE 245 BIOLAB SCIENTIFIC LTD. – AT A GLANCE

 

LIST OF FIGURES

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)

FIG 8 GLOBAL BIOLOGICAL SAFETY CABINET MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 THREAT OF NEW ENTRANTS

FIG 12 INTENSITY OF RIVALRY

FIG 13 THREAT OF SUBSTITUTES

FIG 14 GLOBAL BIOLOGICAL SAFETY CABINET MARKET SNAPSHOT

FIG 15 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 16 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 17 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 18 MAJOR WORLDWIDE MARKETS FOR BIOLOGICAL SAFETY CABINETS, $M

FIG 19 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SNAPSHOT

FIG 20 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 21 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 22 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 23 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2017–2030)

FIG 24 EUROPE BIOLOGICAL SAFETY CABINET MARKET SNAPSHOT

FIG 25 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 26 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 27 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 28 EUROPE BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2017–2030)

FIG 29 APAC BIOLOGICAL SAFETY CABINET MARKET SNAPSHOT

FIG 30 APAC BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 31 APAC BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 32 APAC BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 33 APAC BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2017–2030)

FIG 34 LATAM BIOLOGICAL SAFETY CABINET MARKET SNAPSHOT

FIG 35 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 36 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 37 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 38 LATAM BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2017–2030)

FIG 39 MEA BIOLOGICAL SAFETY CABINET MARKET SNAPSHOT

FIG 40 MEA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 41 MEA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 42 MEA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 43 MEA BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, $M (2017–2030)

FIG 44 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 45 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 46 U.S. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 47 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 48 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 49 CANADA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 50 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 51 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 52 GERMANY BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 53 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 54 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 55 FRANCE BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 56 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 57 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 58 U.K. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 59 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 60 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 61 ITALY BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 62 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 63 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 64 SPAIN BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 65 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 66 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 67 JAPAN BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 68 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 69 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 70 CHINA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 71 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 72 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 73 INDIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 74 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 75 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 76 AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 77 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 78 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 79 SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 80 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 81 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 82 BRAZIL BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 83 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 84 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 85 MEXICO BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 86 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 87 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 88 SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 89 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 90 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 91 SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 92 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, $M (2017–2030)

FIG 93 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY END USER, $M (2017–2030)

FIG 94 U.A.E. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION, $M (2017–2030)

FIG 95 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 96 KEWAUNEE SCIENTIFIC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)